Acadian Asset Management
ACHV icon

Acadian Asset Management’s Achieve Life Sciences ACHV Stock Holding History

Acadian Asset Management’s Portfolio ACHV Stock Details ACHV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-3,704
Closed -$18K – 1654
2022
Q2 		$18K Buy
+3,704
New +$25.1K ﹤0.01% 1621
2016
Q3 		– Sell
-6
Closed -$13K – 1395
2016
Q2 		$13K Hold
6
– – ﹤0.01% 1177
2016
Q1 		$9K Buy
6
+2
+50% +$3.26K ﹤0.01% 1203
2015
Q4 		$12K Buy
4
+2
+100% +$8.45K ﹤0.01% 1206
2015
Q3 		$10K Buy
+2
New +$12.1K ﹤0.01% 1122
2015
Q2 		– Sell
-3
Closed -$13K – 1347
2015
Q1 		$13K Buy
+3
New +$14.7K ﹤0.01% 1162

Other funds holding ACHV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SC
Shay Capital New York $1.2B AUM 37.47% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
CC
Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Acadian Asset Management's ACHV Position: Q3 2022 in Review

Acadian Asset Management sold out of Achieve Life Sciences (ACHV) in Q3 2022, closing a stake of 3,704 shares — an estimated $18K sold.

Acadian Asset Management first reported a position in ACHV in Q1 2015 and held it in 6 quarters. The position peaked at $18K in Q2 2022. 28 funds tracked by Wall St. Rank hold ACHV as of Q3 2022.

  • Acadian Asset Management reported no remaining Achieve Life Sciences position as of Q3 2022 after selling out during the quarter.
  • Acadian Asset Management sold 3,704 Achieve Life Sciences shares in Q3 2022, an estimated $18K.
  • Acadian Asset Management first reported a position in Achieve Life Sciences in Q1 2015 and held it in 6 quarters.
  • Acadian Asset Management's Achieve Life Sciences position peaked at $18K in Q2 2022.
  • 28 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q3 2022.

Based on Acadian Asset Management's 13F filing for Q3 2022, filed 14 Nov 2022.